Published in PLoS One on June 27, 2014
Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci (2016) 0.94
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease. Alzheimers Dement (2015) 0.89
Prions and Protein Assemblies that Convey Biological Information in Health and Disease. Neuron (2016) 0.87
Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner. J Biol Chem (2016) 0.82
Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo. Sci Rep (2016) 0.81
Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathol Commun (2016) 0.80
Roles of tau protein in health and disease. Acta Neuropathol (2017) 0.80
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation. Acta Neuropathol Commun (2016) 0.77
Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics. Front Neurol (2015) 0.76
Monoaminergic neuropathology in Alzheimer's disease. Prog Neurobiol (2016) 0.76
Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research. J Alzheimers Dis (2016) 0.76
A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies. Trends Pharmacol Sci (2017) 0.75
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage. Front Aging Neurosci (2017) 0.75
Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death Dis (2017) 0.75
Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation. Biomolecules (2016) 0.75
The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener (2017) 0.75
Mutant huntingtin is secreted via a late endosomal/lysosomal unconventional secretory pathway. J Neurosci (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53
Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 10.02
Shedding microvesicles: artefacts no more. Trends Cell Biol (2009) 8.84
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 7.52
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (2001) 6.32
Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol (2010) 5.59
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev (2000) 5.40
Trans-synaptic spread of tau pathology in vivo. PLoS One (2012) 4.53
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.85
Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem (2011) 3.57
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell (1999) 3.24
Caspase activation precedes and leads to tangles. Nature (2010) 3.24
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Circulating microparticles: pathophysiology and clinical implications. Blood Rev (2006) 3.07
Lipid raft-associated protein sorting in exosomes. Blood (2003) 2.76
Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem (2012) 2.42
Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol (1995) 2.29
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci (2011) 2.00
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging (2007) 1.65
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet (2001) 1.62
Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci (1996) 1.61
Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep (2013) 1.57
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A (2007) 1.50
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J Neurosci (2004) 1.48
Nuclear tau, a key player in neuronal DNA protection. J Biol Chem (2010) 1.47
Extracellular tau is toxic to neuronal cells. FEBS Lett (2006) 1.47
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res (2012) 1.41
Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis (2010) 1.39
Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci (2014) 1.28
Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol (2004) 1.23
Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem (2000) 1.22
Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. J Biol Chem (2012) 1.22
Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis (2012) 1.20
Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett (2011) 1.17
Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem (2010) 1.15
Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol Aging (2011) 1.13
Secretion of human tau fragments resembling CSF-tau in Alzheimer's disease is modulated by the presence of the exon 2 insert. FEBS Lett (2010) 1.10
Protein degradation, aggregation, and misfolding. Mov Disord (2010) 1.09
Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun (2014) 1.09
Hyperphosphorylation and cleavage at D421 enhance tau secretion. PLoS One (2012) 1.06
Cell-derived microparticles: a new challenge in neuroscience. J Neurochem (2009) 1.05
Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies. J Biol Chem (2012) 1.05
Formation and propagation of tau oligomeric seeds. Front Neurol (2013) 1.04
The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem (2006) 1.03
Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. Int J Alzheimers Dis (2012) 1.02
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med (2012) 0.99
The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain (1996) 0.94
Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy (2010) 0.93
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J (2011) 0.91
Tau as a biomarker of neurodegenerative diseases. Biomark Med (2008) 0.91
Tissue factor, lipid rafts, and microparticles. Semin Thromb Hemost (2010) 0.88
Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics (2013) 0.88
Analysis of human tau in cerebrospinal fluid. J Proteome Res (2010) 0.84
Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J Neurochem (1996) 0.84
Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain. Mol Ther (2013) 0.82
Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol (2013) 0.81
Circulating extracellular vesicles in cancer diagnosis and monitoring: an appraisal of clinical potential. Mol Diagn Ther (2013) 0.80
Phosphorylation of tau alters its association with the plasma membrane. Cell Mol Neurobiol (2000) 0.78
Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors. Gene Ther (2012) 0.77